Association of Physical Activity Levels and Inflammatory Markers Following Pulmonary Rehabilitation
NCT ID: NCT03455153
Last Updated: 2018-10-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
18 participants
OBSERVATIONAL
2018-05-02
2018-10-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In healthy individuals, exercise has been shown to induce an anti-inflammatory response when performed regularly. However, the effects of exercise on inflammation in COPD are unclear. Our initial CIMPRES-COPD study has looked into the effects of short-term exercise, as part of pulmonary rehabilitation, on inflammation. However, this trial will examine the inflammatory response in COPD patients who are most active following pulmonary rehabilitation against those who are least active.
This study will split participants into 2 groups according to physical activity level following pulmonary rehabilitation. We will recruit 40 COPD patients who provided a sample in the initial CIMPRES-COPD study to explore inflammatory responses in those who are most active and least active. By better understanding the mechanisms of how long-term physical activity levels affects inflammation in COPD, we could design better interventions to increase physical activity levels following pulmonary rehabilitation.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Changes in Inflammatory Markers During Pulmonary Rehabilitation Based on Exacerbation States in COPD
NCT02740686
Impact of Feedback on Physical Activity and Health-related Outcomes During Pulmonary Rehabilitation in COPD
NCT02725931
Physical Activity Following Pulmonary Rehabilitation in COPD
NCT03660644
Activity Monitor Use in COPD Patients Undergoing Rehabilitation
NCT02895152
Physical Activity and Self-Efficacy After Pulmonary Rehabilitation
NCT02086383
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Most active
COPD patients with higher physical activity levels as defined by daily step counts.
Physical activity monitoring
COPD patients will wear an accelerometer and complete questionnaires related to daily physical activity levels for 7 days before returning for a clinic visit.
Least active
COPD patients with lower physical activity levels as defined by daily step counts.
Physical activity monitoring
COPD patients will wear an accelerometer and complete questionnaires related to daily physical activity levels for 7 days before returning for a clinic visit.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Physical activity monitoring
COPD patients will wear an accelerometer and complete questionnaires related to daily physical activity levels for 7 days before returning for a clinic visit.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Previously enrolled on pulmonary rehabilitation providing at least one sample for the CIMPRES-COPD trial.
Exclusion Criteria
* Other active inflammatory conditions (e.g. rheumatoid arthritis, cancer).
* Known asthma, allergic rhinitis or other respiratory disease (bronchiectasis, pulmonary fibrosis).
40 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Health Service, United Kingdom
OTHER_GOV
University of Lincoln
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Lindum Medical Practice
Lincoln, Lincolnshire, United Kingdom
Nettleham Medical Practice
Lincoln, Lincolnshire, United Kingdom
Birchwood Medical Practice
Lincoln, Lincolnshire, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
18/WM/0081
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.